RET and non-small cell lung carcinoma: RET fusion refers to the juxtaposition of the 5’-terminal sequence of other genes with the 3’-terminal sequence of RET gene encoding tyrosine, which has been seen in a variety of solid tumors, among which NSCLC is the most common, and RET rearrangement can be detected in about 2% of NSCLC patients [6, 7].